Trenarthan helped a development stage biomedical company to choose the site for a worldwide manufacturing, R&D and headquarters operation. Prior to engaging Trenarthan, this company had tried for four years to enter the European market. Within six months we found an asset acquisition candidate with clean room manufacturing capacity and appropriately trained on site personnel. Trenarthan helped complete the acquisition and obtain a substantial government incentive package.

Trenarthan assisted an early stage medical devices Company with a novel minimally invasive breast tumor laser treatment to commercialize its product in the United States.

Trenarthan advised on marketing, funding and product development. We helped identify strategic partnerships with channels to market, facilitated high level introductions and managed relationships. Trenarthan introduced investors who provided three rounds of angel funding. We located and managed engineering, regulatory and clinical trial management partners.

Trenarthan assisted this company by, among other things: developing persuasive business communication materials and presentations; writing a “White Paper” to seek government funding ; completing applications for government grants; conducting market research; providing a preliminary market assessment covering size of market and potential competitive technologies; developing a business plan and suitable fund raising documents; and generally coordinating all initial business activities of this startup company.